XDEMVY

lotilaner · Tarsus Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XDEMVY, covering 2023-07-24 to 2025-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers [Phase 4]